[Extra-corporeal lithotripsy in children]

O Traxer1, H Lottmann, G Van Kote

  • 1Service d'Urologie de l'Enfant et de l'Adolescent, Fondation Hôpital Saint-Joseph, Paris, France. olivier.traxer@tnn.ap-hop-paris.fr

Insights

Extracorporeal shock-wave lithotripsy (ESWL) is effective for pediatric kidney stones, but long-term effects on growing kidneys require further study. This review examines current ESWL practices in children.

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Medical Technology

Context:

  • Extracorporeal shock-wave lithotripsy (ESWL) is a standard treatment for adult kidney stones.
  • Pediatric use of ESWL has advanced with new technologies, but concerns remain.
  • Published pediatric series since 1986 confirm ESWL's efficacy and minimally invasive nature.

Purpose:

  • To review the current status of ESWL in pediatric patients.
  • To address persistent questions regarding pediatric ESWL, including treatment parameters and long-term effects.
  • To synthesize findings from literature, the GEUP report, and clinical experience.

Summary:

  • ESWL is a safe and effective treatment for pediatric urolithiasis.
  • Second and third-generation lithotripters have improved management of urinary stones in children.
  • Key areas for further investigation include optimal shock wave dosage, inter-session intervals, and renal parenchyma effects.

Impact:

  • Provides a comprehensive overview of pediatric ESWL, aiding clinical decision-making.
  • Highlights areas needing further research to optimize treatment and ensure long-term safety in children.
  • Contributes to the understanding of shock wave effects on the developing renal system.